Risk factors and prevention of viral hepatitis-related hepatocellular carcinoma

X Zhang, L Guan, H Tian, Z Zeng, J Chen… - Frontiers in …, 2021 - frontiersin.org
Hepatocellular carcinoma (HCC) is a common cancer in the world, and its incidence is
increasing yearly. Hepatitis B virus (HBV) infection and hepatitis C virus (HCV) infection are …

The best predictive model for hepatocellular carcinoma in patients with chronic hepatitis B infection

JH Yu, SG Cho, YJ **, JW Lee - Clinical and molecular …, 2021 - pmc.ncbi.nlm.nih.gov
Chronic hepatitis B (CHB) seriously threatens human health. About 820,000 deaths annually
are due to related complications such as hepatitis B and hepatocellular carcinoma (HCC) …

An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B

HY Kim, P Lampertico, JY Nam, HC Lee, SU Kim… - Journal of …, 2022 - Elsevier
Background & Aims Several models have recently been developed to predict risk of
hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB). Our aims were to …

Opportunities to address gaps in early detection and improve outcomes of liver cancer

B McMahon, C Cohen, RS Brown Jr… - JNCI Cancer …, 2023 - academic.oup.com
Death rates from primary liver cancer (hepatocellular carcinoma [HCC]) have continued to
rise in the United States over the recent decades despite the availability of an increasing …

Hepatocellular carcinoma prediction models in chronic hepatitis B: a systematic review of 14 models and external validation

S Wu, N Zeng, F Sun, J Zhou, X Wu, Y Sun… - Clinical …, 2021 - Elsevier
Background & Aims The aim of our study was to characterize the performance of
hepatocellular carcinoma (HCC) prediction models in chronic hepatitis B (CHB) patients …

Emerging insights on immunotherapy in liver cancer

Y Zhang, X Zhang, M Kuang, J Yu - Antioxidants & Redox Signaling, 2022 - liebertpub.com
Significance: Hepatocellular carcinoma (HCC) is a liver malignancy with high mortality rate,
limited treatment options, and poor prognosis. Sorafenib has been the only systemic …

Stratification of hepatocellular carcinoma risk following HCV eradication or HBV control

P Nahon, E Vo Quang, N Ganne-Carrié - Journal of clinical medicine, 2021 - mdpi.com
Hepatocellular carcinoma (HCC) incidence has dramatically decreased in patients infected
with HCV and HBV due to the widespread use of highly effective antiviral agents …

A Liver Stiffness–Based Etiology-Independent Machine Learning Algorithm to Predict Hepatocellular Carcinoma

H Lin, G Li, A Delamarre, SH Ahn, X Zhang… - Clinical …, 2024 - Elsevier
Background & Aims The existing hepatocellular carcinoma (HCC) risk scores have modest
accuracy, and most are specific to chronic hepatitis B infection. In this study, we developed …

[HTML][HTML] Lack of Association between Early On-Treatment HBeAg-Seroclearance and Development of Hepatocellular Carcinoma or Decompensated Liver Cirrhosis

H Shin, WM Choi, SU Kim, Y Ko, Y Park, J Park… - JHEP Reports, 2024 - Elsevier
Abstract Background & Aims The association between hepatitis B virus envelope antigen
(HBeAg)-seroclearance during long-term nucleos (t) ide analogue (NA) treatment and the …

Prediction of the early hepatocellular carcinoma development in patients with chronic hepatitis B virus infection using gadoxetic acid-enhanced magnetic resonance …

M Tang, D Xu, H **, C Song, X Zhou, H Cai, L Li… - BMC cancer, 2024 - Springer
Background Non-hypervascular hypointense nodules (NHHNs) can transform into
hypervascular hepatocellular carcinoma (HCC) during the long-term follow-up. However, the …